343 related articles for article (PubMed ID: 10677243)
1. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
[TBL] [Abstract][Full Text] [Related]
2. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
3. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
4. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
5. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
6. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
Walunas TL; Bluestone JA
J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
[TBL] [Abstract][Full Text] [Related]
8. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
[TBL] [Abstract][Full Text] [Related]
9. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
[TBL] [Abstract][Full Text] [Related]
10. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens.
Lohr J; Knoechel B; Jiang S; Sharpe AH; Abbas AK
Nat Immunol; 2003 Jul; 4(7):664-9. PubMed ID: 12766766
[TBL] [Abstract][Full Text] [Related]
12. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
[TBL] [Abstract][Full Text] [Related]
14. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
15. Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice.
Ablamunits V; Bridgett M; Duffy T; Haag F; Nissen M; Koch-Nolte F; Leiter H
Diabetologia; 2001 Jul; 44(7):848-58. PubMed ID: 11508269
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
19. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
20. CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection.
Saha B; Chattopadhyay S; Germond R; Harlan DM; Perrin PJ
Eur J Immunol; 1998 Dec; 28(12):4213-20. PubMed ID: 9862358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]